Biomarin Pharmaceutical

BMRN13F as of Jun 30, 2026 · next update ~Nov 14

Who's buying BMRN

Top funds mostly added to Biomarin Pharmaceutical in Q2 (Apr⁠–⁠Jun)

Buying:

Funds2InsidersCongress

Top funds
2 of 3 bought more, 1 sold some. Largest: Dodge & Cox, $849.4M (0% of its portfolio).
Insiders
No buys, 5 sales in 12 months.
Congress
No trades disclosed in the last 12 months.

3 funds$1.3B held0.8% avg. weightQ2: 2 bought / 1 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 11 filings

Date	Insider	Type	Shares	Price	Value
Sep 2, 2026	George Eric Davis VP	Sold	17,557	$66.28	$1.16M
May 7, 2026	Gregory R Friberg VP	Sold	3,281	$53.85	$177K
Mar 11, 2026	Charles Greg Guyer VP & CTO	Sold	16,486	$60.46	$997K
Feb 26, 2026	Gregory R Friberg VP	Sold	6,326	$60.38	$382K
Feb 26, 2026	George Eric Davis VP	Sold	26,061	$61.36	$1.60M
May 20, 2025	Erin Burkhart CAO	Sold	1,786	$59.31	$106K
May 2, 2025	Cristin Hubbard VP	Sold	273	$64.92	$18K
Mar 19, 2025	Erin Burkhart CAO	Sold	1,295	$71.52	$93K
Mar 6, 2025	Charles Greg Guyer VP & CTO	Sold	7,034	$71.28	$501K
Feb 24, 2025	Erin Burkhart CAO	Sold	1,344	$68.38	$92K
Nov 12, 2024	Charles Greg Guyer VP & CTO	Sold	5,278	$66.37	$350K